Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab and Lenalidomide in untreated follicular lymphoma
NCT01307605Phase 2Terminated
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Feb 2011
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of lenalidomide in follicular lymphoma (FL), sponsored by Swiss Group for Clinical Cancer Research. Started Feb 2011; status: terminated.
02
Drugs
lenalidomide
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT01307605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01307605.